Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Bioblast Pharma Ltd (ORPN)

2.41 +0.01 (+0.42%)

10/17/2017  3:59pm

Open:

2.43

Pre. Close:

2.40

High:

2.97

Low:

2.35

Volume:

34,483

Market Cap:

8.05M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.02 - 3.05

3.05 - 3.13

Low:

2.22 - 2.26

2.26 - 2.33

Close:

2.34 - 2.38

2.38 - 2.47

Technical analysis  (as of: 2017-10-17 4:40:58 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 3.54     One year: 4.65

Support:

Support1: 1.49    Support2: 1.24

Resistance:

Resistance1: 3.03    Resistance2: 3.98

Pivot:

2.35

Moving Averages:

MA(5): 2.66     MA(20): 2.35

MA(100): 2.73     MA(250): 4.21

MACD:

MACD(12,26): -0.05     Signal(12,26,9): -0.10

%K %D:

%K(14,3): 30.26     %D(3): 41.32

RSI:

RSI(14): 48.06

52-Week:

High: 8.55  Low: 1.49  Change(%): -68.7

Average Vol(K):

3-Month: 4243  10-Days 14743

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ORPN has closed below upper band by 45.2%. Bollinger Bands are 42.4% wider than normal. The large width of the bands suggest high volatility as compared to ORPN's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

Sat, 02 Aug 2014 15:23:40 GMT
2.40

Mon, 05 Jun 2017 20:34:04 GMT
BRIEF-Bioblast Pharma to seek strategic alternatives including partnership and ...

Fri, 26 May 2017 20:15:00 GMT
Bioblast Pharma Reports First Quarter 2017 Financial Results

Mon, 12 Sep 2016 09:56:15 GMT
Bioblast Pharma Reports Results of a Clinical Trial of Trehalose in ...

Wed, 01 Feb 2017 21:00:00 GMT
Bioblast Pharma Provides Clinical and Development Updates on Trehalose as a ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

3.00

Shares Float (M)

1.48

% Held by Insiders

40.50

% Held by Institutions

17.01

Shares Short (K)

155

Shares Short Prior Month (K)

148

Stock Financials

EPS

-3.670

EPS Est. Current Year

-0.820

EPS Est. Next Year

-0.730

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

1.410

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-55.8

Return on Equity (ttm)

-119.2

Qtrly Rev. Growth

Gross Profit (p.s.)

-2.695

Sales Per Share

EBITDA (p.s.)

-3.320

Qtrly Earnings Growth

Operating Cash Flow (M)

-10.54

Levered Free Cash Flow (M)

-4.86

FoxReading.com

Valuation

P/E

-0.66

P/E Growth Ratio

P/BV

1.71

P/S

P/CF

-0.69

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.